ArticleAdvanced therapeutics2020

Novel nanococktail of a dual PI3K/mTOR inhibitor and cabazitaxel for castration-resistant prostate cancer.

Yee Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.